117 North Church Street, Moorestown, NJ 08057

856.642.6226 [phone ] ||| 856.642.6336 [fax]

 

About Us
» Our Team
» In the news

» Business & Civic Participation
» News Releases
» Awards


Services
Specialized
Practice Areas
» Education
» Energy
» Development /
Redevelopment

» Healthcare


Client Profiles


Clients
»Clients In The News


Contact
»Directions

»Employment
Opportunities

 

 

 

 

 

 

 

 

 

 

 

© 2007 Thomas/Boyd Communications

With the wide array of issues surrounding healthcare today, from topical discussions about aging baby boomers to the increasing cost of healthcare to controversies surrounding stem cell research, effective communications is highly valued in the healthcare field.

At Thomas/Boyd Communications we support our healthcare clients with an expertise that encompasses every facet of this highly specialized field. From the “bread and butter” communications tools of news releases, feature stories and newsletters that bring human interest stories to the forefront to working closely with physicians and scientists to translate highly technical concepts into laymen’s terms, TBC is an integral member of our healthcare clients’ marketing communications teams.


CORIELL INSTITUTE FOR MEDICAL RESEARCH

SJ Magazine Article

 

Courier-Post Article

Launch of the Personalized Medicine Project

At a Congressional briefing hosted by Rep. Robert Andrews (D-NJ) in Washington, DC, Coriell Institute officially launched the Coriell Personalized Medicine Collaborative. Rep. Andrews, in support of the initiative, was the first volunteer to be consented and to submit a saliva sample from which his DNA will be isolated to determine his personal genome profile. Thomas/Boyd coordinated coverage of the event including writing and distributing the media advisory, news releases and conducted extensive media follow up to secure coverage, which included front page coverage by Gannett. This event was a launching point for further coverage in the Philadelphia Business Journal, NJBIZ, the local NPR affiliate, SJ Magazine and area television.

The CPMC seeks to discover presently unknown genes that elevate a person’s risk of cancer and other complex diseases, to understand why people respond differently to treatments, and to explore how the resulting information can best be viewed and utilized by participants and their physicians in a secure, user-friendly, web-based system. Participants will have the opportunity to learn about their risks for medically actionable conditions, including cancer, heart disease, diabetes, high blood pressure and cholesterol, and use this information to take preventative measures for their improved health. There is no cost to participants.